Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Clinical trial NCT05236686 · RECRUITING

Trial details

NCT number: NCT05236686
Sponsor: Shanghai Gynecologic Oncology Group
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2022-02-15
Primary completion: 2025-12-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.